» Authors » D Palma

D Palma

Explore the profile of D Palma including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 220
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Diaz Y, Palma D, Vargas-Leguas H, Rodrigo T, Molina-Pinargorte I, Casas X, et al.
Int J Tuberc Lung Dis . 2024 Apr; 28(5):237-242. PMID: 38659139
<sec id="st1"><title>OBJECTIVE</title>To describe the characteristics of people indicated for directly observed treatment (DOT) in Spain, and the factors associated with unsuccessful treatment.</sec><sec id="st2"><title>METHODS</title>This was a multicentre observational study based on...
2.
Gulstene S, Ruwanpura T, Palma D, Joseph N
Clin Oncol (R Coll Radiol) . 2022 Sep; 34(11):733-740. PMID: 36050221
Stereotactic ablative radiotherapy (SABR) is an important curative-intent treatment option for early-stage non-small cell lung cancer. It offers good cancer control without invasive surgery and has become the standard of...
3.
Unger B, Gillman L, Hickey K, Pace D, Lam-Tin-Cheung K, Catton J, et al.
Can J Surg . 2022 Apr; 64(6 Suppl 2):S80-S159. PMID: 35483046
No abstract available.
4.
5.
Cochran L, Hill S, Lotti U, Allenspach K, Palma D, Forman M, et al.
J Small Anim Pract . 2021 Mar; 62(7):588-598. PMID: 33660270
Objectives: To describe the clinical characteristics and long-term outcome of Escherichia coli-associated granulomatous ileocolitis in dogs. Methods: Retrospective review of medical records from dogs with periodic acid-Schiff positive (PAS+) granulomatous...
6.
Patel P, Shiarli A, Tree A, McDonald F, Palma D, Gomez D
Clin Oncol (R Coll Radiol) . 2020 Mar; 32(6):409-410. PMID: 32201159
No abstract available.
7.
Patel P, Palma D, McDonald F, Tree A
Clin Oncol (R Coll Radiol) . 2019 Jun; 31(12):824-833. PMID: 31182289
Oligoprogressive disease is a relatively new clinical concept describing progression at only a few sites of metastasis in patients with otherwise controlled widespread disease. In the era of well-tolerated targeted...
8.
Zhang T, Rodrigues G, Louie A, Palma D, Dar A, Dingle B, et al.
Curr Oncol . 2018 Mar; 25(1):22-31. PMID: 29507480
Background: We designed a phase i study of concurrent chemoradiotherapy (ccrt) with docetaxel (D) and cisplatin (C), followed by consolidation dc, for unresectable stage iii non-small cell lung cancer (nsclc)....
9.
Ronden M, van Sornsen de Koste J, JOHNSON C, Slotman B, Spoelstra F, Haasbeek C, et al.
Int J Radiat Oncol Biol Phys . 2017 Nov; 100(1):115-121. PMID: 29102278
Purpose: To investigate, in the setting of stereotactic ablative radiation therapy (SABR) for early-stage non-small cell lung cancer, the incidence and patterns of change in high-risk radiologic features (HRFs) in...
10.
Grimm J, Palma D, Xue J, Senan S
Med Phys . 2017 May; 39(6Part13):3760. PMID: 28517351
Purpose: NTCP analysis was performed with Lyman model to study the dose tolerance limits for radiation-induced pneumonitis (RP) in hypofractionated SBRT. Since SBRT is increasingly being applied for the treatment...